GERONTOLOGY, published by KARGER in Switzerland, is a prominent journal dedicated to the study and understanding of aging, with a keen focus on the interdisciplinary aspects of geriatric medicine and gerontology. Established in 1957, it has provided a platform for cutting-edge research that covers a wide range of topics including, but not limited to, the biological, psychological, and sociological aspects of aging. With an impressive ranking that places it in the Q3 category for Aging and Q2 for Geriatrics and Gerontology as of 2023, the journal continues to attract high-quality submissions from researchers worldwide, evidenced by its Scopus rankings, which position it favorably within relevant fields. While it operates under a subscription model, the journal remains committed to advancing knowledge that informs practice and policy within an aging society. By fostering innovative studies and discussions, GERONTOLOGY serves as an essential resource for researchers, health professionals, and students alike, dedicated to the care and understanding of older adults.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

CHRONOBIOLOGY INTERNATIONAL, a distinguished journal published by Taylor & Francis Inc, is at the forefront of research in the fascinating field of chronobiology, encompassing the physiological aspects of circadian rhythms and their impact on biological processes. Established in 1984, this journal serves as an essential resource for researchers, clinicians, and students, providing groundbreaking insights into how time-related factors influence health and disease. With an impressive ranking in the Q2 quartile for both Physiology and Medical Physiology categories and a commendable positioning within the Scopus metrics, it reflects the high-quality research it publishes. Although not categorized as an open-access journal, CHRONOBIOLOGY INTERNATIONAL provides a vital platform for disseminating innovative studies that bridge gaps in our understanding of physiological rhythms, making it indispensable for those dedicated to advancing knowledge in this dynamic field.

NEUROPSYCHOBIOLOGY, published by KARGER, is a leading academic journal that has been at the forefront of exploring the intricate relationships between neuroscience and psychological processes since its inception in 1975. With both an ISSN of 0302-282X and an E-ISSN of 1423-0224, the journal is renowned for its rigorous peer-reviewed articles and significant contributions to the fields of Biological Psychiatry, Neuropsychology, and Physiological Psychology. Its impact is reflected in its esteemed Scopus rankings, standing out in the 92nd and 81st percentiles in their respective categories. With a commitment to advancing understanding in mental health and neurological science, NEUROPSYCHOBIOLOGY is classified in the Q3 and Q1 quartiles, making it a vital resource for researchers, clinicians, and students alike. Based in Switzerland, the journal embraces a holistic approach to psychological research, bridging gaps between theoretical frameworks and practical applications, thus promoting impactful advancements in the understanding of the human mind.
Explore the latest findings and theories with NEUROPSYCHOBIOLOGY, where your work can contribute to the evolving landscape of neuropsychological studies.

Canadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.

ADDICTION BIOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to advancing the understanding of addiction science. With an impressive impact factor and recognized as a Q1 journal in Medicine, Pharmacology, and Psychiatry and Mental Health, ADDICTION BIOLOGY occupies a crucial position in the scientific discourse surrounding the biological and neurochemical underpinnings of addictive behaviors. Since its inception in 1996, the journal has been at the forefront of research, fostering interdisciplinary collaborations and promoting innovative studies that explore the complexities of addiction. Researchers and professionals benefit from the journal's commitment to high-quality manuscripts, offering essential insights into prevention, treatment, and rehabilitation strategies for substance use disorders. Although it does not offer open access, ADDICTION BIOLOGY remains accessible through various academic libraries, ensuring that groundbreaking studies reach a global audience. This journal is indispensable for anyone seeking to deepen their knowledge in the rapidly evolving field of addiction research.

BIOESSAYS, published by WILEY, is a leading academic journal dedicated to the dynamic fields of biochemistry, genetics, and molecular biology. With an impressive impact factor and recognized as a Q1 journal in its category for 2023, it ranks 49 out of 221 in the Scopus database, placing it within the 78th percentile among its peers. Since its inception in 1984, BIOESSAYS has served as a vital platform for researchers, professionals, and students, facilitating the dissemination of pivotal findings, innovative theories, and review articles that shape the current understanding of biological sciences. Although it does not offer open access, the journal remains key for those seeking to stay at the forefront of scientific discovery and discussion within this ever-evolving discipline. With its commitment to high-quality, peer-reviewed content, BIOESSAYS continues to influence future research directions and academic discourse.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, published by Elsevier Science Ltd, is a premier scholarly journal dedicated to advancing the field of cardiology and cardiovascular medicine as well as molecular biology. With an impressive Q1 ranking in both categories as of 2023, the journal boasts a significant influence in the scientific community, evidenced by its Scopus rankings—33rd out of 387 in Cardiology and 65th out of 410 in Molecular Biology. Established in 1970 and continuing to publish groundbreaking research through 2024, the journal’s mission is to disseminate innovative findings that enhance our understanding of cardiovascular health at the molecular and cellular levels. Although it is not an open-access publication, it attracts top-tier research contributions, making it essential reading for researchers, healthcare professionals, and students aiming to stay ahead in the dynamic domains of cardiovascular and molecular biology research.

Immunity & Ageing is a distinguished open access journal published by BMC, committed to advancing the understanding of the interplay between immunological processes and aging. Since its inception in 2004, this journal has established itself as a leading platform for disseminating quality research, evidenced by its Q1 rankings in both Aging and Immunology categories for 2023. With an impressive Scopus ranking that places it in the top percentile of related fields, it serves as an essential resource for researchers, professionals, and students eager to explore the nuances of immune aging and age-related diseases. The journal's open access policy ensures wide accessibility and visibility, promoting collaborative discourse and innovation across the global scientific community. Based in the United Kingdom, Immunity & Ageing is set to continue its significant contribution to the field, inviting submissions that push the boundaries of knowledge and application in immunology and gerontology.